| http://www.w3.org/ns/prov#value | - Associations such as the National Hemophilia Foundation, Plasma Protein Therapeutics Association, and the Immune Deficiency Foundation successfully campaigned on behalf of fractionators and patients for the exclusion of plasma derived therapeutics from certain private health insurance and government provisions that are intended to reduce drug prices by allocating a greater portion of the burden to
|
